From: Designing of inhibitors against drug tolerant Mycobacterium tuberculosis (H37Rv)
Fingerprint | MCC-based descriptors | Frequency based descriptors | Hybrid (MCC + Frequency) | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 | Sen.a | Spec.b | Acc.# | MCC! | AUC!! | Sen.a | Spec.b | Acc.# | MCC! | AUC!! | Sen.a | Spec.b | Acc.# | MCC! | AUC!! |
PubChem | 59.85 | 56.92 | 58.78 | 0.16 | 0.61 | 60.00 | 41.15 | 53.11 | 0.01 | 0.51 | 58.60 | 57.44 | 58.17 | 0.15 | 0.61 |
MACCS | 53.95 | 58.85 | 55.74 | 0.12 | 0.58 | 54.39 | 53.72 | 54.15 | 0.08 | 0.54 | 64.35 | 61.15 | 63.19 | 0.25 | 0.66 |
EState | 67.31 | 59.74 | 64.54 | 0.26 | 0.66 | 64.13 | 58.59 | 62.11 | 0.22 | 0.64 | 66.86 | 58.85 | 63.93 | 0.25 | 0.65 |
SubFP | 64.43 | 64.10 | 64.31 | 0.28 | 0.65 | 59.70 | 44.62 | 54.19 | 0.04 | 0.53 | 66.20 | 63.33 | 65.15 | 0.29 | 0.66 |
Hybrid-4 | 72.55 | 62.82 | 68.99 | 0.35 | 0.73 | 66.13 | 59.10 | 63.56 | 0.25 | 0.67 | N.A | N.A | N.A | N.A | N.A |